Fresh concerns have emerged about the platelet studies underpinning the FDA approval of ticagrelor, AstraZeneca's ...

AstraZeneca expansion to turn Maryland facility into one of largest focused on just cell therapy. ... The cell therapy building and labs in Rockville are scheduled to open in early 2026.

AstraZeneca’s expanding footprint in the US includes, among others: A state-of-the-art R&D centre in Kendall Square, Cambridge, Massachusett... AstraZeneca’s 9M and Q3 2024 results ...

AstraZeneca plans to build a $2.5 billion research and development center in Beijing, the Britain-based multinational pharmaceutical announced Friday.

AstraZeneca has refuted allegations its staff “refuse to cooperate and respect” the U.K. marketing code. | AstraZeneca has refuted allegations its staff “refuse to cooperate and respect ...

AstraZeneca disclosed Wednesday that Leon Wang, a high-ranking executive who oversees international operations and is also president of its subsidiary in China, is under investigation by Chinese ...

AstraZeneca will pay $18 million to biotechnology firm Immunai Inc to use the New York-based firm's AI model of the immune system to make certain cancer drug trials more efficient, the latter said ...

The detained individuals, all Chinese nationals, were associated with the marketing of oncology drugs in China, where AstraZeneca generates approximately 13% of its global revenue.

AstraZeneca reported earnings per share of $4.03, a year-over-year increase of 5%. In this way, Soriot said, the company is able to better "manage the turbulences" of the geopolitical landscape.

Drawn up syringes containing the AstraZeneca COVID-19 vaccines and the empty vial are seen in a tray at the Claremont Showgrounds Covid-19 Vaccination Clinic on May 03, 2021 in Perth, Australia.

According to the Telegraph, AstraZeneca admitted for the first time in court documents that its COVID-19 vaccine can cause rare side effects such as blood clots and low blood platelet counts.